Colorectal Cancer Diagnostics Market to Reach USD 6.3 Billion by 2035, Driven by FOB Tests and Hospital-Associated Labs

The global colorectal cancer diagnostics market is set for significant growth over the next decade, fueled by rising cancer prevalence, increasing awareness of early detection, and advancements in diagnostic technologies. According to recent market insights, the industry is projected to expand from USD 2.8 billion in 2025 to USD 6.3 billion by 2035, registering a CAGR of 8.5%. Fecal occult blood (FOB) tests remain the dominant test type, while hospital-associated laboratories continue to be the primary end-users.

Market Outlook: Strong Growth Over the Next Decade

The global colorectal cancer diagnostics market is forecast to reach USD 6.3 billion by 2035, up from USD 2.8 billion in 2025. During the forecast period, the industry is expected to register a CAGR of 8.5%, reflecting rising demand for early cancer detection and improved patient outcomes.

The growing emphasis on preventive healthcare and screening programs is driving the adoption of advanced diagnostic solutions. Colorectal cancer, being one of the most common cancers worldwide, requires timely detection to reduce mortality rates. Early screening using FOB tests, colonoscopy, and other molecular diagnostic tools is increasingly recommended by healthcare authorities, fueling market expansion.

Full Market Report available for delivery. For purchase or customization, please request here – https://www.factmr.com/connectus/sample?flag=S&rep_id=70

Key Growth Drivers

1. Increasing Prevalence of Colorectal Cancer – The rising incidence of colorectal cancer globally is a primary factor driving the need for diagnostic tests. Aging populations and lifestyle changes contribute significantly to this trend.
2. FOB Tests Leading the Market – Fecal occult blood tests are expected to remain the most widely used test type segment due to their cost-effectiveness, non-invasive nature, and wide accessibility.
3. Hospital-Associated Labs as Key End-Users – Hospitals and affiliated laboratories continue to dominate the end-user segment, offering comprehensive screening and diagnostic services to large patient populations.
4. Technological Advancements – Innovations in molecular diagnostics, immunochemical assays, and next-generation sequencing (NGS) are enhancing the accuracy and efficiency of colorectal cancer detection.
5. Government Screening Programs – National and regional colorectal cancer screening initiatives, especially in North America and Europe, are driving demand for diagnostic solutions.
6. 
   

Competitive Landscape: Key Players and Strategies

The colorectal cancer diagnostics market is competitive, with global players investing heavily in R&D, strategic partnerships, and product innovation. Key companies are expanding their portfolios to include both traditional FOB tests and advanced molecular diagnostics.

• Abbott Laboratories: Focuses on immunoassay-based screening tests and advanced molecular diagnostics.
• Roche Diagnostics: Offers a wide range of colorectal cancer detection solutions, including PCR-based tests and companion diagnostics.
• Siemens Healthineers: Provides laboratory automation and molecular diagnostic platforms to enhance testing efficiency.
• Bio-Rad Laboratories: Concentrates on immunochemical and PCR-based diagnostics for early cancer detection.
• Other Key Players: Thermo Fisher Scientific, Hologic, and Quest Diagnostics are leveraging strategic partnerships, acquisitions, and technological innovation to strengthen market presence.

Emerging startups are also developing personalized and minimally invasive testing solutions, challenging traditional diagnostics while providing opportunities for collaboration with established players.

Browse Full Report https://www.factmr.com/report/70/colorectal-cancer-diagnostics-market

Regional Insights

• North America: Dominates the market, driven by government screening programs, high healthcare expenditure, and patient awareness about early detection. The U.S. remains a key revenue contributor due to advanced healthcare infrastructure.
• Europe: Steady growth is observed due to early screening adoption and regulatory support for advanced diagnostics in countries like Germany, France, and the UK.
• Asia-Pacific: Expected to witness the fastest growth due to rising cancer prevalence, expanding healthcare infrastructure, and increasing awareness in countries such as China, Japan, and India.
• Latin America & Middle East: Emerging markets with increasing healthcare investment and growing awareness of colorectal cancer screening are showing steady adoption.

Recent Market Developments

• Companies are investing in molecular diagnostics and NGS-based solutions to improve the accuracy and efficiency of colorectal cancer detection.
• Strategic alliances with hospitals and laboratory networks are increasing the availability of diagnostic services worldwide.
• Regulatory approvals and clinical trials are enhancing the credibility and adoption of advanced testing solutions.
• Integration of digital healthcare platforms and telemedicine is supporting remote sample collection, analysis, and result reporting.

These developments underscore the dynamic nature of the colorectal cancer diagnostics market and the importance of innovation to remain competitive.

Future Outlook

The global colorectal cancer diagnostics market is expected to grow strongly over the next decade. Key trends shaping the market include:

• Expansion of FOB tests with improved sensitivity and ease of use.
• Increasing adoption of molecular and genetic testing solutions for personalized cancer care.
• Growth in hospital-associated and specialized laboratory networks to cater to rising patient demand.
• Integration of AI-based tools and digital platforms to enhance diagnostic accuracy and streamline patient management.

Companies that successfully combine innovation, clinical efficacy, and accessibility will maintain a competitive edge in this rapidly evolving market.

About Fact.MR

Fact.MR is a leading global market research and consulting firm, providing actionable insights to help businesses make informed strategic decisions across industries.

Check out More Related Studies Published by Fact.MR Research:

Metastatic Colorectal Cancer Market

Cancer Therapeutics Market

Cancer Genomic Testing Market

Cancer Biomarkers Market

Cancer Supportive Care Product Market